To: Board of Directors and Leadership

Psychedelic Science Funders Collaborative (PSFC)

Dear Members of the Board,

I am writing to request remedial action addressing patient safety and sexual misconduct risks within the psychedelic therapy ecosystem.

In recent years, the field has faced documented cases of sexual misconduct in psychedelic settings, raising serious questions about oversight, prevention, and survivor support across institutions shaping this emerging health sector.

As an organization coordinating philanthropic funding that influences research, policy, and institutional partnerships, PSFC occupies a position of significant influence within the psychedelic ecosystem. With that influence comes heightened responsibility to ensure strong ethical safeguards, transparent governance practices, and meaningful protections for patients.

Public reporting and investigative records have documented historical contact networks associated with convicted sex trafficker Jeffrey Epstein, and investigative reporting has also raised governance concerns regarding financial transparency and the handling of sexual misconduct reporting within the psychedelic ecosystem. While appearance in such records does not constitute an assessment of wrongdoing, nonprofit governance standards increasingly encourage organizations to conduct heightened due diligence when individuals appearing in such records hold positions of influence within philanthropic, research, or healthcare funding networks.

Taken together, reported staff and members appearing in Epstein-related contact records, alongside investigative reporting raising concerns regarding financial oversight and sexual misconduct reporting practices, raise broader questions about systemic risk within the ecosystem. Networks associated with sexual exploitation and trafficking have historically relied on opaque access to elite philanthropic, academic, and investment environments where influence, funding, and reputational cover converge.

At the same time, documented intelligence operations—including historical programs and more recent influence campaigns associated with the Epstein case—demonstrate how emerging psychological and biomedical fields can attract actors seeking strategic leverage. When influence, capital, and institutional authority become concentrated within a small network of organizations and funders, governance vulnerabilities can create opportunities for misconduct, reputational compromise, or exploitation by actors operating through trafficking or other influence networks.

When an organization such as PSFC sits at the center of funding flows, research priorities, and institutional relationships within a developing sector, weak transparency and governance safeguards can create exposure not only to misconduct but also to systemic reputational risk. Under these conditions, the concentration of influence itself becomes a structural risk to the long-term health and legitimacy of the sector.

At present, state-level initiatives across the United States are already developing policy frameworks, community infrastructure, and practitioner ecosystems for psychedelic services. These state-level efforts are often better positioned to support community infrastructure, public education, and local implementation efforts than centralized philanthropic coordination.

At the same time, major gaps remain in psychedelic research funding. Areas including women’s health, sexual trauma, and research involving historically underserved populations remain significantly underfunded despite representing critical patient safety and access priorities.

For these reasons, redistributing funding away from centralized philanthropic coordination and toward independent community initiatives and underfunded research areas would better support the long-term integrity and safety of the emerging psychedelic healthcare sector.

Given the seriousness of these issues and PSFC’s central coordinating role within the ecosystem, I respectfully request that the organization consider the following remedial actions:

A. Voluntary Dissolution of PSFC

Initiate an orderly dissolution process and redistribute the organization’s remaining assets to independent organizations with documented governance safeguards, financial transparency standards, and sexual misconduct prevention policies.

B. Redirect the Estimated $130M Funding Pipeline

Redistribute the estimated $130 million philanthropic funding pipeline currently coordinated through PSFC according to the following structure:

State and local initiatives are already building the infrastructure that philanthropic funding seeks to support. Redirecting funding toward community-level organizations would strengthen transparency, patient safety, and grassroots governance within the ecosystem.

Grantmaking should prioritize:

• Local psychedelic societies and community-based organizations

• Grantees providing clear financial transparency and governance safeguards

• Organizations implementing sexual misconduct prevention and reporting policies

• Programs supporting veteran mental health and veteran access to care

• Indigenous-led organizations and communities stewarding traditional knowledge

Critical research areas remain significantly underfunded within the psychedelic ecosystem. Directing funding toward these research gaps would address urgent patient safety and public health needs.

Grantmaking should prioritize:

• Women’s health research related to psychedelics

• Research addressing sexual trauma and trauma-informed care

• Research involving historically underserved populations, including women

• Institutions demonstrating strong financial transparency and safeguards against sexual misconduct

C. Publication of a Transparency Report

Release a public report documenting:

• Governance safeguards used during the redistribution of funding

• Recipient organizations and grantmaking criteria

• Policies implemented to ensure financial transparency and patient safety protections

These requests reflect governance precedent established in People of the State of New York v. Trump Foundation, in which the New York Attorney General required the Donald J. Trump Foundation to dissolve and distribute its charitable assets following governance failures.

Given the importance of patient safety and public trust in the emerging psychedelic healthcare sector, this correspondence will be shared with relevant stakeholders within the field.

We respectfully request a written response within 30 days.

We further request that this correspondence be circulated to the full Board of Directors and entered into the organization’s governance records for review and discussion at the next scheduled board meeting.

Sincerely,

The Undersigned Signatories